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The outbreak and rapid spread of novel Coronavirus SARS-CoV-2 has resulted in global pandemic. The purpose of this 
work is to provide an ethnopharmacological overview of selected medicinal plants having antiviral activity along with their 
applications to treat COVID-19 related symptoms based on fragmented literature. Hundreds of published research articles 
were screened and reviewed using online search engines such as PubMed, PMC and Google Scholar with relevant keywords 
related to coronavirus, antiviral medicinal plants, phytochemical compounds, cough and fever. A total of 12 plants having 
antiviral activity against a number of viruses were documented with their probable mechanism of action. Most of the studied 
plants and their compounds were also reported to have other therapeutic potentials and were used to boost immunity, treat 
cough, fever, tiredness, difficulty in breathing and diarrhoea, which are common symptoms of COVID-19 infections as per 
World Health Organization. This review hopefully opens a new horizon in the development of antiviral drug against novel 
coronavirus COVID-19. 
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The COVID-19, 2019-nCoV or SARS-CoV-2 virus, 
all stand for a single virus nomenclature which was 
reported during December 2019 in Wuhan, China. 
Initial studies have revealed that COVID-19 is less 
pathogenic compared to the other coronaviruses 
(CoV), however, the transmission ability is much 
higher1. The same is evident from the escalating 
number of infections around the world since the day 
of inception. On 11th March, 2020, the World Health 
Organization confirmed COVID-19 as a pandemic, 
which cost an anticipated $30 to $100 billion in 
worldwide economy2.  
Within less than three months, it has affected as 
many as 213 countries and territories and two 
international conveyances (the Diamond Princess 
Cruise ship harboured in Yokohama, Japan and the 
Holland America's MS Zaandam cruise ship). As of 
1st August, 2020, the number of confirmed cases 
registered worldwide account for above 18 million 
and a total of around 688,247 people were affected by 
this deadly virus having a fatality rate of 3.82%. 
China, from where the virus was first reported1, 
topped the list in terms of registered cases followed 
by Italy and USA during March 2020. In contrast to 
this, by 15th April, USA had taken the first position 
based on the number of confirmed cases followed by 
Spain, Italy, France, Germany and others 
(www.worldometers.info/coronavirus/), whereas USA 
struggles to save the lives of its people and stands first 
in the tally of the death toll which is increasing with 
the passage of time followed by Italy and Spain.  
India, the second largest populated country in the 
world, recorded its first case of infection on 30th 
January, 2020, in a patient having a travel history 
from Wuhan University, China, to Kerala state. 
During February, 2020, there were only two cases of 
COVID-19 in India, however, it increased at an 
exponential rate since March 2020 and by 1st August, 
2020 it reached over 1.80 million, of which 38,165 
were reported dead with mortality rate of 2.11% 
(www.covid19india.org). A total of nearly 1.19 
million people recovered from the impact of the 
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deadly virus. The COVID-19 virus has affected the 
entire geographical territory of India. Of all the States 
and Union Territories, Maharashtra, Tamil Nadu, 
Andhra Pradesh, Karnataka and Delhi were severely 
affected.  
With the passage of time, the number of confirmed 
cases, death toll, and the number of countries affected 
by COVID-19 are ever increasing and have become a 
matter of deep concern. People are fighting for their 
lives in hospitals to combat the virus and till date no 
successful antiviral oral drug exists to prevent the 
pandemic as it takes several months of research to 
develop an effective drug/vaccine against a novel 
infection3. In this period of struggle and race to 
combat COVID-19, the traditional herbal medicine 
emerges as a first line of defence for the people 
especially in India4.  
Herbal medicines have been an indispensable part 
of the healthcare system of the people inhabiting the 
developing countries since ancient times5,6. 
Innumerable plants are already established as drugs 
for various ailments including bacterial, fungal, viral 
etc., but their effectiveness towards COVID-19 is yet 
to be affirmed by clinical trials. This review focuses 
on 12 potential candidates majorly found in India that 
have been reported to possess antiviral activities 
against various viruses in addition to being effective 
in treating COVID-19 related symptoms such as 
fever, cough, tiredness, difficulty in breathing and 
diarrhoea. 
Plants as a source of drug 
Advantages and disadvantages 
The following specific advantages help us to 
proceed for drug development from plant sources: 
• The ethnomedicinal history of the candidate
plants opens up a horizon for investigation since
the long-term use by humans is presumed to be
relatively safer compared to unexplored ones7.
• Botanical resources exhibit incredible chemical
and structural diversity. The structural diversity in
turn helps the researchers to create novel
chemical entities using the tools of in-silico drug
designing8.
• Drug development from botanical sources is also
associated with certain disadvantages:
• Drug development from botanical sources may
result in overexploitation of the candidate due to
commercialization7.
• Nowadays, there is an increasing trend of
protecting the traditional formulation or drugs by
the intellectual property rights. These in turn limit
the drug discovery process at various stages9.
Potentiality of the bioactive compounds to become 
a drug 
The existing standards for drug discovery in 
pharmaceutical industries and scientific confinement 
in isolating novel compounds with desirable activity 
limit the development of new drugs. Koehn and 
Carter10 listed a number of attributes for the bioactive 
compounds from plant origin to be an effective drug 
molecule such as increased chirality, steric 
complexity, oxygen atoms, hydrogen bond acceptors 
and donors, molecular rigidity, lower ratio of aromatic 
ring atoms to total heavy atoms and wider distribution 
of molecular property. The complexity of chemical 
entities of plant origin makes it a daunting task for 
medicinal chemists to initiate the drug discovery 
process11. 
Though an enormous number of phytochemicals 
are known to be biochemically active and have 
favorable absorption, distribution, metabolism, 
excretion and toxicity profiles but all cannot be 
considered to be effective drugs. 
Complementary and alternative medicines and 
coronavirus  
Coronavirus (Coronaviridae family; CoV), is a 
single-stranded RNA virus, found to be the root cause 
of respiratory tract infections in mammals as well as 
avians. The World Health Organization delegated 
three major pathogenic viruses rising from animal 
reservoirs such as severe acute respiratory syndrome 
coronavirus (SARS-CoV), Middle East respiratory 
syndrome coronavirus (MERS-CoV) and novel 
coronavirus (2019-nCoV/SARS-CoV2) popularly 
known as COVID-19, which is considered highly 
fatal. The use of saikosaponins (A, B2, C and D) from 
Bupleurum spp. was explored by Cheng et al.12 for its 
antiviral activity against HCoV-22E9. They inhibit 
viral attachment and penetration stages of virus12.  
Lin et al.13 identified plant derived inhibitors such as 
myricetin and scutellarein against SARS-CoV 
enzymes (nsP13 helicase and 3CL protease) from 
Isatis indigotica. 
Methodology  
Based on the rationale, an online search was 
performed during 15th March to 15th April, 2020 using 
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various bibliographical databases, PubMed, PMC and 
Google Scholar, using coronavirus and medicinal 
plants as key words along with anti-viral, anti-pyretic, 
anti-fatigue, anti-dyspnoea, anti-diarrhoeal, cough etc. 
To ensure the scientific names with respect to the 
accepted names, synonyms, families, author citations 
we searched plant database such as “International 
Plant Names Index” (www.ipni.org). Hundreds of 
articles were reviewed for this purpose, but only 
relevant papers were screened for extracting the 
related information (Fig. 1). 
Probable potential candidate species that can 
inhibit Covid-19 
A large number of plants and phytochemical 
compounds have been documented for control of 
viruses and future drug development. In this review 
we discuss 12 medicinal plants that emerged to have 
broad spectrum antiviral activity besides being 
used to treat cough, fever, diarrhoea and shortness of 
breath etc. 
Azadirachta (A.) indica A. Juss. 
A household name amongst Indians, A. indica 
(Family: Meliaceae) is popularly known as neem. 
It finds its application in all form of medicines like 
Ayurveda, Unani, and Homeopathy for treating 
various diseases since centuries14. Neem is laden with 
a number of bioactive molecules which are effective 
as anti-inflammatory, anti-ulcer, anti-diabetic, 
immune-modulator, anti-mutagenic, anti-carcinogenic, 
antioxidant and anti-viral drugs15. Sairam et al.16 
reported the antiviral activity of neem oil (NIM-76) 
against polio vaccine in Vero cell line by restraining 
the replication of the virus. Similar type of activity 
was also reported by Parida et al.17 in their study on 
the impact of aqueous extract of neem leaves on 
dengue virus type-2 in C6/36 cells. Though the exact 
mechanism of action is not clear, it is evident from the 
above studies that they interfere possibly with viral 
replication, their envelop structure and thus help 
control the viral infections18. A total of 173 patents 
were granted since 2000 as reported by Singh et al.19. 
Camellia (C.) sinensis (L.) Kuntze 
Beverage tree crop, C. sinensis (Family: Theaceae) 
is native to Southeast Asia and it is the most widely 
consumed drink globally next to water. It is rich in 
polyphenolic flavonoids, catechins. Four different 
forms of catechins are reported in tea leaves viz., e (-) 
-epicatechin (EC), (-) -epicatechin-3-gallate (ECG),
(-) -epigallocatechin (EGC) and (-)-epigallocatechin-
3-gallate (EGCG) 20. EGCG and EGC are the most
abundant and largely explored on medical grounds21. 
The efficacy of EGCG was studied to combat 
Hepatitis C virus (HCV) by Calland et al.22 They 
found that EGCG had the potential to inhibit the entry 
either by altering the virion or by blocking interaction 
between the envelop glycoprotein (gB and gD) and 
the virus. This study is in consonance with earlier 
study on the effect of EGCG on HIV where it binds to 
the CD4 cells, restricting the binding of viral 
glycoproteins to CD4 cells and thus suppressing viral 
infection23. In 2012, Ling et al.24 systematically 
tested the anti-influenza A activity of EGCG on 
Madin-Darby canine kidney cells and inferred that 
EGCG has the potential to inhibit the replication of 
influenza A. Liang et al.25 evaluated the efficacy of 
(+) -catechin in swine testicle cell lines against 
transmissible gastroenteritis coronavirus infection and 
revealed that (+) -catechin impaired the viral RNA 
replication and prevent infection. 
Cinnamomum sp. 
Cinnamon botanically known as Cinnamomum sp. 
(Family: Lauraceae), a spice known for its fragrance 
finds its utilization not only in cooking but also in 
medicine26. The resinous compounds present in 
cinnamon helps to inhibit the entry of HIV-1 into the 
host cells probably by binding itself with the HIV-1 
virion27. Premanathan et al.28 screened bark of 
Cinnamomum cassia against HIV-1 and HIV-2 in Fig. 1 — Flow chart of the research design 
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MT-4 cells and found it to be effective against both 
the infections. In 2016, Connell et al.29 assessed the 
anti-HIV-1 activity of cinnamon-derived compound 
(IND02) and opined that this compound not only 
obstructs viral replication but also binds to the viral 
envelop glycoprotein and prevent infection. In 
addition to this, IND02 restrains T cell exhaustion by 
restoring the population of CD4+ T cell30. In a 
separate study, Fauvella and his team30 experimented 
the anti-HCV activity of IND02. They inferred that 
IND02 obstructs the HCV viral entry but does not 
have any role to play in its replication. 
Curcuma (C.) longa L. 
Turmeric, scientifically know as C. longa (Family: 
Zingiberaceae), is largely explored on scientific 
grounds to validate its therapeutic effects11,31,32. 
Curcumin, the principal ingredient in C. longa has a 
plethora of pharmacological properties. The anti-viral 
activity of C. longa in general and curcumin in 
particular has been screened and validated against a 
number of viruses by different researchers. The anti-
viral activity of curcumin is well established in case 
of HIV, different scientists have reported different 
mechanisms of action against HIV virus. Mazumder 
et al.33 and Gupta et al.34,35 hypothesized that 
curcumin and its derivatives inhibit the activity of 
HIV-1 integrase enzyme. Ali and Banerjea36 studied 
the effect of curcumin on HIV-1 Tat protein which is 
associated with viral replication and revealed that 
curcumin inhibits HIV-1 by degrading the viral Tat 
protein. In an attempt to evaluate the anti-HCV 
activity of curcumin in hepatoma cell lines and 
primary human hepatocytes, Anggakusuma et al.37 
concluded that curcumin hinders the entry of HCV 
irrespective of its genotypes. Besides these, curcumin, 
the active component of C. longa has been effective 
against Coxsackievirus, Enterovirus 71(EV71) and 
Rift Valley fever virus by inhibiting viral 
replication38-40, Chikungunya virus and Human 
Norovirus by obstructing the viral entry in the 
host40,41. In case of Influenza A virus, curcumin 
combats the virus by three mechanisms by attacking 
envelop (i.e., virus inhibition) in addition to limiting 
viral replication and entry42,43.
Emblica (E.) officinalis Gaertn. or Phyllanthus (P.) emblica L. 
E. officinalis, P. emblica or Indian gooseberry
(Family: Phyllanthaceae), rejuvenating herb is known 
as Amla in India44. A number of studies have been 
carried out to assess the anti-HIV activity of amla 
over years. Bothiraja et al.45 observed the anti-HIV 
activity of E. officinalis by detecting viral p24 antigen 
concentration. They inferred that E. officinalis can 
help treat HIV-1 by reducing viral load. In 2012, two 
studies reported the anti-HIV-1 activity of 
P. emblica46,47. Both experiments revealed the anti-
HIV-1 reverse transcriptase activity of P. emblica.
P. emblica was also subjected to determine anti-
HSV-1 and anti-HSV-2 activity48,49. Qu et al.48 opined
that P. emblica can be a potential anti-HSV therapy
based on their results. Xinag et al.49 established that
1,2,4,6 tetra‐O‐galloyl β D glucose, isolate of
P. emblica retarded the viral entry and pacified viral
particles. Lv et al.50 isolated sesquiterpenoid 
glycosides from P. emblica and checked for its anti-
Hepatitis B virus activity. They surmised that the 
glycoside altered HBsAg and HBeAg secretions. 
Liu et al.51 and Wang et al.52 evaluated the efficacy 
of Norsesquiterpenoids and Phyllaemblicin B 
respectively in the management of Coxsackie virus 
B3 (CVB3). Liu et al.51 employed HeLa cells to 
assess the virucidal activity of Noresesquiterpenoids 
and revealed that they possess strong anti-CVB3 
activity. Wang et al.52 also used HeLa cell line and 
elucidated that Phyllaemblicin B has potent anti-
CVB3 activity. The compound not only inhibited the 
replication of CVB3 virus but also induced apoptosis. 
In an in silico approach, Amini and Mansouri53 
established that the ursolic acid from P. emblica has 
the potential to impede E1 and E2 proteins, which are 
the major component of Human Papilloma Virus 
DNA replication and thus have 
anti-HPV activity.  
Foeniculum (F.) vulgare Mill. 
F. vulgare or Fennel (Family: Apiaceae), is an
aromatic herb with culinary and medicinal uses. This 
plant is bestowed with a number of health benefits 
since antiquity54 and a lot of work has been carried 
globally to ascertain the same. However, this virtually 
remains unexplored for probable antiviral activity. 
Orhan and his team55 evaluated the virostatic efficacy 
of fennel against Herpes simplex type-1 (HSV-1) and 
parainfluenza type-3 on Vero cells and found it to be 
effective against both of the viruses but the 
mechanism was not known54.  
Mentha (M.) spicata L. 
Spearmint or M. spicata (Family: Lamiaceae) is a 
perennial aromatic herb used in various delicacies55. 
A number of reports are available which justify its 
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medicinal use in conditions such as common cold56 
and digestive disorders57 but there are only a few 
reports on antiviral activity of Mentha sp. 
Ocimum (O.) sanctum Linn. 
Tagged as “Extract of Life”, O. sanctum (Family: 
Lamiaceae) is also popular as Tulsi. It is a holy herb 
with immense health benefits58. A boon for the 
treatment for cold and cough, tulsi has been reported 
to have antiviral activity against hepatitis and 
encephalitis based on clinical trials59-61. The anti-HSV 
activity of O. sanctum was studied using green 
monkey kidney cell lines. O. sanctum demonstrated 
multiple effects such as restricting viral entry, viral 
replication and thus established to possess antiviral 
activity against HSV62. Tulsi plant was subjected to 
test for antiviral activity against dengue virus-1 
(DENV-1) on HepG263. It showed cytopathic effect 
and thus inhibited DENV-1, besides it also hindered 
viral replication. Rege and Chowdhary64 made an 
attempt to ascertain O. sanctum as a potential 
candidate against HIV. They reported triple 
mechanism of action of O. sanctum against HIV viz., 
obstructing the gp120 and CD4 interaction, hindering 
HIV-reverse transcriptase and HIV-protease enzyme. 
Picrorhiza (P.) kurroa Royle ex Benth. 
P. kurroa (Family: Plantaginaceae) or Kutki, a herb
is well recognized for its hepatoprotective activity in 
the traditional system of medicine65. Several 
experiments have been carried out to evaluate the 
antiviral activity of P. kurroa on hepatitis virus but 
their mechanism of action is not reported66,67. Win et 
al.68 employed TREx-HeLa-Vpr cell lines to assess 
the anti-viral protein A (Vpr) of bis-iridoid glycosides 
isolated from P. kurroa. The glycosides suppressed 
the expression of Vpr and thus were established as 
natural inhibitor of Vpr. 
Tinospora (T.) cordifolia (Willd.) Miers ex Hook. f. & 
Thomson 
T. cordifolia (Family: Menipsermaceae), 
commonly referred as Guduchi or Giloy is an immune 
boosting climber. It is a storehouse of many bioactive 
constituents thus has myriad applications in the field 
of pharmaceuticals69. Kalikar et al.70 made an attempt 
to investigate the role of T. cordifolia in the 
management of HIV. They focused mainly on six 
parameters namely total leukocyte count, differential 
leukocyte count, erythrocyte sedimentation rate, 
platelet count, haemoglobin among the HIV patients 
and found that T. cordifolia was mainly effective in 
suppressing the HIV associated symptoms with 
decreased eosinophil count and haemoglobin70,71. The 
HIV-1 reverse transcriptase inhibition activity of 
Guduchi was studied by Estari et al.72, they reported 
that the plant was effective in inhibiting the HIV-1RT 
and thus possesses anti-HIV activity. Recently in 
2019, the protective effect of silver nanoparticles 
obtained from T. cordifolia was evaluated against 
Chikungunya virus in Vero cell lines73. The 
investigators reported that T. cordifolia has the 
potential to inhibit Chikungunya virus. 
Withania (W.) somnifera (L.) Dunal 
Aswagandha or Indian ginseng, botanically known 
as W. sominifera (Family: Solanaceae) is an 
indigenous plant having a number of therapeutic 
uses74. Grover et al.75 explored the antiviral potential 
of a steroidal lactone, Withaferin A obtained from W. 
sominifera against HSV in silico and validated it be 
effective in hindering the viral replication. The human 
neuronal cell line, SK-N-MC was employed to 
ascertain the anti-HIV activity of aswagandha and it 
was noted that aswagandha could inhibit HIV-1 
related disorders76.  
Zingiber (Z.) officinale Rosc. 
Ginger, scientifically referred as Z. officinale Rosc. 
(Family: Zingiberaceae), a spice that has been shown 
to demonstrate innumerable therapeutic effects 
against various ailments in India and China77. A 
plethora of researches have been conducted on this 
medicinal plant. Imanishi et al.78 used Madin-Darby 
canine kidney cells to investigate the anti-influenza 
A/Aichi/2/68 (Aichi) virus of Z. officinale. It was 
found that Z. officinale did not have any direct impact 
on the virus but was able to suppress the viral load by 
activating the macrophage and producing TNF-α. 
Same laboratory from Germany, carried out two 
experiments to ascertain the anti-HSV activity of 
ginger oil using African green monkey kidney cells 
(R-37 cells)79,80. Schnitzler et al.79 concluded that 
ginger oil was able to inhibit HSV-1 virus prior to 
adsorption. Similar mode of action was reported by 
Koch et al.80 while working on HSV-2 virus. A 
number of studies were carried out to screen the 
influence of Z. officinale on HCV81-83. Experimental 
studies revealed that ginger suppressed viral 
replication and thus inhibited HCV grown on 
hepatocellular carcinoma HepG2 cell line.82 El-
Wahab et al.81 also reported similar mechanism 
against the virus. In another study, Abdel-Moneim et 
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al.83 suggested that Z. officinale was potent in 
depleting hepatitis C viral load. Solvent based study 
was carried out by Sharma et al.84,85 to establish the 
modulatory effect of Z. officinale (methanolic and 
aqueous) on matrix metalloproteinases and tissue 
inhibitors of metalloproteinases on dengue virus 
infected C6/36 cell lines. Both the methanolic and 
aqueous extracts of ginger prevent dengue-virus 
infections by down regulating and up regulating the 
expression of matrix metalloproteinases and tissue 
inhibitors of metalloproteinases, respectively.  
The plants under study are rich source of 
pharmacologically active metabolites such as 
curcumin, phyllaemblicin B, azadiractin, eugenol, 
berberine, tinosporin and withaferin A. They exert the 
activity either singly or in synergy (Fig. 2A and 2B).  
Fig. 2 — (A&B): Chemical structure of the major components having antiviral activity (Courtesy: https://pubchem.ncbi.nlm.nih.gov/
accessed on 6th June, 2020) 
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The targets of herbal products against CoVs 
Active compounds, found in herbal formulations of 
Indian origin, have shown antiviral activity by acting 
on several molecular targets as illustrated in Table 1. 
Authors reviewed the targets of natural products 
against coronavirus. These targets include the binding 
domain of the SARS-CoV-2 spike protein, coronavirus 
main 3-chymotrypsin-like cysteine protease, papain-
like protease, SARS-CoV-2 RNA-dependent RNA 
polymerase, SARS-CoV-2 endoribonucleoase other 
kinase such as viral helicase and the host receptor 
human angiotensin−converting enzyme86.  
The prospective of natural compounds for clinical 
management of COVID-19 
The spike protein(S) fundamentally known as entry 
protein is the primary determinant of tropism. 
Angiotensin−converting enzyme 2 is expressed in a 
wide variety of tissues and is also found in lower 
respiratory tract101. The S protein binds to the host 
receptor angiotensin−converting enzyme 2 and 
undergoes conformational changes leading to 
proteolytic cleavage of its protein by cathepsin or 
other proteases aiding in fusion of viral and cellular 
membrane. After fusion, the genomic material (RNA) 
binds directly to host ribosome and gets translated in 
two large proteases: 3-chymotrypsin-like cysteine 
protease and papain-like protease by proteolysis for 
packaging new virions87. To replicate RNA genome, 
virus encodes a specific replicase, named RdRp. 
Therefore, the virus needs four specific protein 
entities to exhibit its pathogenicity. Hence, targeting 
these proteins could be the possible cure for SARS-
CoV-2. Previous genomic studies of COVID-19 
indicated that catalytic sites of the four COVID-19 
enzymes are highly conserved and showed similarity 
to SARS and MERS enzyme88. So it is wise to use 
drug repurposing approach using existing MERS and 
SARS inhibitors for COVID-19 treatment89.  
The coronavirus spike (S) N-glycoprotein is also 
the main target for vaccine development as it is 
antigen presented at viral surface and recognized by 
the host immune system of the infected host. This S-
protein is responsible for host cell non-covalent 
attachment, which makes it special for the future drug 
designing approach and infection90.
Conclusions and future perspectives
Viral infection especially COVID-19 is a major 
threat to mankind and public health. During the last 
two decades, the world has witnessed the emergence 
and resurgence of a number of novel and deadly 
viruses which pose a serious threat to human health 
such as Nipah virus (1999), SARS-CoV (2002-03), 
Swine H1N1 influenza A virus (2009), MERS-CoV 
(2012), Ebola virus (2014-16), Zika virus (2015). The 
sequence similarity and phylogenetic analysis of 
SARS-CoV2 against a collection of other known 
coronavirus sequences found that it can be classified 
as β-coronavirus88. The ongoing outbreak of the 
pandemic virus COVID-19, which has created havoc 
globally, spreads its wings over 213 countries and two 
international conveyances. Though the world cannot 
restrict such outbreaks, with the development in the 
field of science and technology, researchers are well 
equipped to identify the pathogens within a short span 
of time. Despite advancement in development of 
antiviral drugs, there are still special needs to find 
new antiviral agents to combat the multi-drug 
resistant viruses that are evolving.  
At present, the entire world is grappling for the 
drugs to overcome the pandemic caused by COVID-
Table 1 — Plants and their natural compounds for clinical management of COVID-19 
Plant name Compound Target 
Azadirachta indica Azadirachtin IS-Spike protein inhibitor92, PL-Pro protein inhibitor91, SARS-CoV-2 MPro inhibitor93 
Camellia sinensis (-)-epigallocatechin-3-gallate All the three sites of spike protein94 
(+) –catechin Spike-protein near RBD site and ACE295 
Curcuma longa Curcumin RBD site of Spike-protein and ACE295, SARS-CoV-2 MPro and ACE2 inhibitor96 
Emblica officinalis Phyllaemblicin B SARS-CoV-2 MPro inhibitor97 
Mentha sp  Carvone SARS-CoV-2 MPro inhibitor, SARS-CoV-2 SPro inhibitor98 
Ocimum sanctum Eugenol SARS-CoV-2 MPro and ACE2 inhibitor96 
Tinosporin Spike glycoprotein inhibitor, SARS-CoV-2 MPro inhibitor, RdRp inhibitor99 
Cordioside Spike glycoprotein inhibitor, SARS-CoV-2 MPro inhibitor, RdRp inhibitor99 
Withania somnifera Withanone SARS-CoV-2 MPro inhibitor100 
Withaferin A Spike glycoprotein inhibitor99, SARS-CoV-2 MPro inhibitor99, RdRp inhibitor99, 
SARS-CoV-2 MPro inhibitor101 
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19 either synthetic or herbal. Therefore, drug 
repurposing using plant sources could be used as an 
alternative to heal the world. Plants have always been 
an indispensable part of drugs for various ailments 
since time immemorial and virus is no exception. The 
published literatures affirm the antiviral activity of a 
significant number of plants that have been or could 
be used as a potential drug either singly or in 
combination to overcome viral outbreak. 
A total of 12 plants viz., A. indica, C. sinensis, 
Cinnamomum sp., C. longa, E. officinalis, F. vulgare, 
M. spicata, O. sanctum, P. kurroa, T. cordifolia, W.
somnifera, Z. officinale which have been in news as
effective against COVID-19 since the outbreak has
been reviewed to examine their efficacy. The above
mentioned plants have been found effective against a
number of viruses such as Influenza A, HCV, HIV-1,
HIV-2, Polio virus, T-gastroenteritis coronavirus,
hepatitis B virus, Coxsackievirus, Enterovirus 71, Rift
Valley fever virus, Chikungunya virus, human
Norovirus, herpes simplex virus 1 and 2, human
Papilloma virus, Parainfluenza virus-1, dengue virus,
human respiratory synctial virus, human Rota virus,
vesicular stomatitis virus etc.
Synthetic medicines might be able to manage 
symptoms quickly in infected patients, but may have 
severe side effects. These herbal medications have the 
benefits of low toxicity. These products could be a 
good immune-modulator and manage cytokines 
linked with immune responses and enhance resistance 
to viral infection by improving immune system. 
It was evident from the literature that the plants 
were effective in reducing viral load by restricting 
viral entry into the host, inhibiting viral replication, 
obstructing the gp 120 and CD4 interaction, hindering 
viral-reverse transcriptase, viral-protease enzyme, 
degrade viral Tat protein etc. Therefore, based on the 
above review, we may infer that these plants may be 
effective in prevention and management of COVID-
19 either individually or in conjunction with each 
other. It is the need of hour to explore these plants and 
try to formulate, standardize and evaluate a 
formulation against COVID-19 which play a major 
role in antiviral drug development. 
Challenges and limitations 
Some of the key issues connected with herbal 
formulations and compounds derived from natural 
sources include a lack of knowledge regarding the 
mechanism of action of herbal compounds in a 
particular disease and their influence on various 
targets. As indicated in this review, these products 
could help in the treatment of COVID-19 via a variety 
of mechanism. Bioavailability and solubility are the 
key hurdles in developing a natural product to drug 
therapeutics, as the major compounds covered in this 
research only have in-silico validations91. Hence, the 
success rate, amount of time consumed and high cost 
involved eventually challenge these compounds to 
enter in clinical trials.  
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